Details for Patent: 10,709,713
✉ Email this page to a colleague
Which drugs does patent 10,709,713 protect, and when does it expire?
Patent 10,709,713 protects ANJESO and is included in one NDA.
This patent has eighteen patent family members in nine countries.
Drugs Protected by US Patent 10,709,713
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,709,713
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 431131 | ⤷ Sign Up | |||
| Canada | 2517679 | ⤷ Sign Up | |||
| Germany | 602004021107 | ⤷ Sign Up | |||
| Denmark | 3090731 | ⤷ Sign Up | |||
| Denmark | 3434261 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
